Life sciences market experts from Optum and Advisory Board share perspectives on trends that will influence the future drug value chain.
Related healthcare insights
Article
Optum Life Sciences experts discuss value-based contracts at the 5th Annual Gene Therapy for Rare Disorders Conference.
Article
AbbVie Vice President Chris Boone discusses what the life sciences industry can do to realize precision medicine’s full potential.
Article
Discover insights from Dr. John Seeger’s recent participation at the Duke-Margolis Thirteenth Annual Sentinel Initiative Public Workshop.